Suppr超能文献

鞘氨醇-1-磷酸载体 Spns2 同源物 2 对于肝细胞癌中铁调节转移是必需的。

Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.

机构信息

Department of Nutrition, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China; Institute of International Medical Science and Technology, Sanda University, Shanghai 201209, China.

Department of Nutrition, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, China.

出版信息

Mol Ther. 2022 Feb 2;30(2):703-713. doi: 10.1016/j.ymthe.2021.09.012. Epub 2021 Sep 20.

Abstract

Iron dyshomeostasis is associated with hepatocellular carcinoma (HCC) development. However, the role of iron in HCC metastasis is unknown. This study aimed to elucidate the underlying mechanisms of iron's enhancement activity on HCC metastasis. In addition to the HCC cell lines and clinical samples in vitro, iron-deficient (ID) mouse models were generated using iron-free diet and transferrin receptor protein knockout, followed by administration of HCC tumors through either orthotopic or ectopic route. Clinical metastatic HCC samples showed significant ID status, accompanied by overexpression of sphingosine-1-phosphate transporter spinster homolog 2 (SPNS2). Mechanistically, ID increased SPNS2 expression, leading to HCC metastasis in both cell cultures and mouse models. ID not only altered the anti-tumor immunity, which was indicated by phenotypes of lymphatic subsets in the liver and lung of tumor-bearing mice, but also promoted HCC metastasis in a cancer cell autonomous manner through the SPNS2. Since germline knockout of globe SPNS2 showed significantly reduced HCC metastasis, we further developed hepatic-targeting recombinant adeno-associated virus vectors to knockdown SPNS2 expression and to inhibit iron-regulated HCC metastasis. Our observation indicates the role of iron in HCC pulmonary metastasis and suggests SPNS2 as a potential therapeutic target for the prevention of HCC pulmonary metastasis.

摘要

铁代谢失衡与肝细胞癌(HCC)的发生发展有关。然而,铁在 HCC 转移中的作用尚不清楚。本研究旨在阐明铁增强 HCC 转移活性的潜在机制。除了体外 HCC 细胞系和临床样本外,还通过无铁饮食和转铁蛋白受体蛋白敲除生成缺铁(ID)小鼠模型,然后通过原位或异位途径给予 HCC 肿瘤。临床转移性 HCC 样本显示出明显的 ID 状态,同时过度表达神经鞘氨醇-1-磷酸转运蛋白 Spns2。在机制上,ID 增加了 SPNS2 的表达,导致细胞培养和小鼠模型中的 HCC 转移。ID 不仅改变了抗肿瘤免疫,这表现为荷瘤小鼠肝脏和肺部中淋巴亚群的表型,而且通过 SPNS2 以肿瘤细胞自主的方式促进 HCC 转移。由于球形 SPNS2 的种系敲除显示 HCC 转移明显减少,因此我们进一步开发了肝靶向重组腺相关病毒载体来敲低 SPNS2 表达并抑制铁调节的 HCC 转移。我们的观察表明铁在 HCC 肺转移中的作用,并提示 SPNS2 可能是预防 HCC 肺转移的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a6/8821935/b02108a05be5/fx1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验